Jan. 9, 2020: Bone loss after HIV treatment initiation; aging and antiretroviral dosage; more U=U evidence for women; viral suppression and executive function.
Nov. 7, 2019: Zoledronic acid to prevent bone loss; bone benefits for older patients switching from TDF to TAF; periperhal artery disease among women; motor dysfunction and cognitive impairment.
June 27, 2019: Long-term viability of NRTI-free salvage therapy; factors associated with HIV treatment interruption; evolution of frailty risk among older people; skin and soft tissue infections among people with HIV.
The effect of HIV treatment on HPV risk; bone mineral density declines in women vs. men; how hep C cure affects kidney function; when it comes to non-daily PrEP, location matters.
HIV infection increased the risk of a new fracture by 32% in a mostly premenopausal group in the Women's Interagency HIV Study (WIHS). Older age, white race, previous fracture history, injection drug use, opiate use and smoking also independently rai...
HIV-positive people are at increased risk for thinning bones or reduced bone density. Thinner bones are weaker and have difficulty supporting a person's weight, therefore, they are prone to break or fracture.
After an average of five years in a recent study, bone scans revealed that in general HIV-positive women had reduced bone density in their hips and thighs compared to HIV-negative women.
Still poorly understood in the medical community, bone disease in older HIV-positive women was the topic at hand in a talk from Dr. Savannah Cardew at the 4th International Workshop on Women & HIV.
Low Bone Mineral Density in HIV-Infected Women (Oral 102) Authored by D. Jacobson, T. Knox, A. Shevitz, S. Gorbach View the original abstract
HIV Infection and Protease Inhibitor Use Are Not Associated With Reduced Bone Mineral Density in ...